Clearmind Medicine Inc.

NasdaqCM:CMND Stock Report

Market Cap: US$7.0m

Clearmind Medicine Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Adi Zuloff-Shani

Chief executive officer

US$295.6k

Total compensation

CEO salary percentage69.3%
CEO tenure3.4yrs
CEO ownershipn/a
Management average tenure2.5yrs
Board average tenure3.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Adi Zuloff-Shani's remuneration changed compared to Clearmind Medicine's earnings?
DateTotal CompensationSalaryCompany Earnings
Jul 31 2024n/an/a

-US$8m

Apr 30 2024n/an/a

-US$7m

Jan 31 2024n/an/a

-US$8m

Oct 31 2023US$296kUS$205k

-US$9m

Jul 31 2023n/an/a

-US$6m

Apr 30 2023n/an/a

-US$7m

Jan 31 2023n/an/a

-US$7m

Oct 31 2022n/an/a

-US$7m

Jul 31 2022n/an/a

-US$7m

Apr 30 2022n/an/a

-US$7m

Jan 31 2022n/an/a

-US$4m

Oct 31 2021US$145kUS$113k

-US$3m

Compensation vs Market: Adi's total compensation ($USD295.57K) is below average for companies of similar size in the US market ($USD650.00K).

Compensation vs Earnings: Adi's compensation has been consistent with company performance over the past year.

CEO

Adi Zuloff-Shani (56 yo)

3.4yrs

Tenure

US$295,573

Compensation

Dr. Adi Zuloff-Shani, Ph D., serves as Member of Scientific Advisory Board at N2OFF, Inc. (formerly known as Save Foods, Inc.) since October 2021. She serves as Chief Executive Officer of Clearmind Medicin...

Leadership Team

NamePositionTenureCompensationOwnership
Adi Zuloff-Shani
Chief Executive Officer3.4yrsUS$295.57kno data
Alan Rootenberg
Chief Financial Officer2.5yrsUS$67.14k0%
$ 0
Mark Haden
Vice President of Business Development3.4yrsno data0%
$ 0
Mylene Touboul
Accounting Managerless than a yearno datano data
Adi Varon
Controllerless than a yearno datano data

2.5yrs

Average Tenure

69yo

Average Age

Experienced Management: CMND's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Mark Haden
Vice President of Business Development3.3yrsno data0%
$ 0
John Krystal
Member of Scientific Advisory Board2.5yrsno datano data
Michael Davidson
Member of Scientific Advisory Boardno datano datano data
Alon Friedman
Member of Scientific Advisory Boardno datano datano data
Wim van den Brink
Member of Scientific Advisory Board3.2yrsno datano data
Oz Adler
Independent Director3yrsUS$36.05k0%
$ 0
Amitai Weiss
Independent Chairman5.3yrsUS$216.96k0.98%
$ 68.5k
Yehonatan Shachar
Independent Director4.7yrsUS$26.12k0.31%
$ 21.5k
Gabriele Fischer
Member of Scientific Advisory Board3.2yrsno datano data
Gal Yadid
Member of Scientific Advisory Boardno datano datano data
Christian Schutz
Member of Scientific Advisory Board2.6yrsno datano data
Asaf Itzhaik
Independent Director2yrsUS$22.73k0.31%
$ 21.5k

3.2yrs

Average Tenure

57yo

Average Age

Experienced Board: CMND's board of directors are considered experienced (3.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 08:31
End of Day Share Price 2024/12/26 00:00
Earnings2024/07/31
Annual Earnings2023/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Clearmind Medicine Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution